A detailed history of United Services Automobile Association transactions in Alkermes Plc. stock. As of the latest transaction made, United Services Automobile Association holds 10,815 shares of ALKS stock, worth $388,258. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,815
Previous 10,815 -0.0%
Holding current value
$388,258
Previous $302,000 2.98%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.01 - $28.55 $55,062 - $68,320
-2,393 Reduced 18.12%
10,815 $302,000
Q2 2024

Aug 06, 2024

BUY
$23.21 - $27.24 $9,284 - $10,896
400 Added 3.12%
13,208 $318,000
Q1 2024

May 15, 2024

BUY
$26.4 - $32.56 $338,131 - $417,028
12,808 New
12,808 $346,000
Q3 2019

Nov 13, 2019

SELL
$19.51 - $24.28 $3.89 Million - $4.84 Million
-199,271 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$21.47 - $37.33 $439,770 - $764,630
20,483 Added 11.46%
199,271 $4.49 Million
Q1 2019

May 13, 2019

BUY
$28.4 - $36.49 $825,588 - $1.06 Million
29,070 Added 19.42%
178,788 $6.52 Million
Q4 2018

Feb 13, 2019

SELL
$27.94 - $44.61 $17,238 - $27,524
-617 Reduced 0.41%
149,718 $4.42 Million
Q2 2018

Sep 27, 2018

SELL
$40.56 - $51.36 $2.04 Million - $2.58 Million
-50,281 Reduced 25.06%
150,335 $6.19 Million
Q2 2018

Aug 10, 2018

BUY
$40.56 - $51.36 $2.11 Million - $2.67 Million
52,056 Added 35.04%
200,616 $9.38 Million
Q1 2018

May 14, 2018

BUY
$53.61 - $67.26 $1.11 Million - $1.39 Million
20,682 Added 16.17%
148,560 $8.61 Million
Q4 2017

Feb 14, 2018

SELL
$47.69 - $55.39 $1.77 Million - $2.06 Million
-37,189 Reduced 22.53%
127,878 $7 Million
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $8.11 Million - $8.99 Million
165,067
165,067 $8.39 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.